MASTROIANNI, Claudio Maria
 Distribuzione geografica
Continente #
NA - Nord America 19.933
EU - Europa 7.925
AS - Asia 4.338
AF - Africa 217
SA - Sud America 147
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 2
Totale 32.588
Nazione #
US - Stati Uniti d'America 19.633
IT - Italia 4.014
SG - Singapore 1.659
IN - India 1.174
SE - Svezia 1.086
CN - Cina 914
FI - Finlandia 552
DE - Germania 456
UA - Ucraina 442
IE - Irlanda 366
CA - Canada 255
ID - Indonesia 227
BG - Bulgaria 200
GB - Regno Unito 195
RO - Romania 160
MY - Malesia 136
AR - Argentina 109
TG - Togo 89
FR - Francia 84
NL - Olanda 73
BE - Belgio 58
AT - Austria 40
TR - Turchia 38
PK - Pakistan 35
RU - Federazione Russa 31
HK - Hong Kong 29
CZ - Repubblica Ceca 27
IR - Iran 27
MX - Messico 25
BR - Brasile 24
PL - Polonia 23
BZ - Belize 19
GR - Grecia 19
EG - Egitto 18
SC - Seychelles 17
ET - Etiopia 16
AU - Australia 15
CH - Svizzera 15
VN - Vietnam 15
JP - Giappone 14
ZA - Sudafrica 14
BJ - Benin 12
KR - Corea 12
PH - Filippine 12
LU - Lussemburgo 11
MK - Macedonia 11
NZ - Nuova Zelanda 11
RS - Serbia 11
ES - Italia 10
GH - Ghana 9
PT - Portogallo 9
SA - Arabia Saudita 9
LT - Lituania 8
NG - Nigeria 8
CL - Cile 7
GE - Georgia 5
HR - Croazia 5
HU - Ungheria 5
IQ - Iraq 5
CM - Camerun 4
PE - Perù 4
TD - Ciad 4
BD - Bangladesh 3
BI - Burundi 3
CO - Colombia 3
DZ - Algeria 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
QA - Qatar 3
SO - Somalia 3
TH - Thailandia 3
TZ - Tanzania 3
AL - Albania 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EU - Europa 2
KE - Kenya 2
KG - Kirghizistan 2
LY - Libia 2
NP - Nepal 2
TN - Tunisia 2
TW - Taiwan 2
UG - Uganda 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MA - Marocco 1
MU - Mauritius 1
PA - Panama 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 32.588
Città #
Fairfield 2.873
Chandler 1.599
Rome 1.567
Ashburn 1.400
Woodbridge 1.319
Singapore 1.153
Seattle 1.042
Houston 999
Dearborn 969
Cambridge 909
Wilmington 907
Ann Arbor 760
Princeton 669
San Paolo di Civitate 522
Plano 417
Lawrence 387
Dublin 357
Santa Clara 334
Beijing 304
Millbury 294
San Diego 252
Boston 246
Jakarta 222
Milan 216
Fremont 212
Sofia 200
New York 197
Helsinki 186
Jacksonville 165
Andover 161
Ottawa 136
Norwalk 117
Boardman 110
Federal 107
San Mateo 94
Lomé 89
Toronto 89
Des Moines 63
Bremen 60
Brussels 54
Kunming 54
San Jose 52
Falls Church 51
Munich 48
Dallas 47
Hefei 47
London 46
Nanjing 42
Los Angeles 39
Phoenix 39
Guangzhou 37
Horia 35
Hebei 34
Naples 34
Vienna 33
Bühl 32
Pune 31
Jinan 29
Nanchang 28
Mannheim 26
Hong Kong 25
Lappeenranta 24
Brno 23
Falkenstein 23
Stockholm 22
Frankfurt am Main 21
Padova 20
Amsterdam 19
Belize City 19
Chicago 19
Hyderabad 19
Latina 19
Shanghai 19
Buffalo 17
Grafing 17
Catania 16
Florence 16
Groningen 15
Palermo 15
Redwood City 15
Shenyang 15
Genoa 14
Prato 14
Washington 14
Fuzhou 13
Mexico City 13
Rawalpindi 13
Warsaw 13
Zhengzhou 13
Bologna 12
Brescia 12
Islamabad 12
Mahé 12
Nuremberg 12
Paris 12
Athens 11
Atlanta 11
Cairo 11
Chennai 11
Hangzhou 11
Totale 23.173
Nome #
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study 217
Surgical site infection after caesarean section. Space for post-discharge surveillance improvements and reliable comparisons 207
Study of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-negative migrants and HIV-infected patients attending an outpatient clinic in Rome. 154
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 147
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 144
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 142
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 137
Detection of Biofilm-associated Implant Pathogens in Cardiac Device Infections: High Sensitivity of Sonication Fluid Culture Even in the Presence of Antimicrobials 128
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 122
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) 121
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 119
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 113
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis 113
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients. Another COVID-19 paradox? 113
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report 111
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 111
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease 111
Antimicrobial essential oil formulation: chitosan coated nanoemulsions for nose to brain delivery 110
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 105
Retinal involvement and ocular findings in COVID-19 pneumonia patients 104
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 104
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 103
Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis 102
Does lung ultrasound have a role in the clinical management of pregnant women with SARS COV2 infection? 101
Toll-like receptor 4-dependent platelet-related thrombosis in SARS-CoV-2 infection 100
Multifunctional analysis of CD4+T-cell response as immune-based model for tuberculosis detection 100
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality 100
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients 99
Therapeutic strategy for pan-drug resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen 98
Diagnostic issues of asymptomatic neurosyphilis in HIV-positive patients. A retrospective study 98
Oral bacteriotherapy in patients with COVID-19: a retrospective cohort study 98
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) 97
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series 96
Challenges in the management of SARS-CoV2 infection. The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19 96
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) 96
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 94
Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients 94
Sonicazione dei dispositivi intracardiaci impiantabili: implicazioni microbiologiche e patogenetiche nelle infezioni associate a devices cardiaci 93
Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy 93
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? 93
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value 93
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 93
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients. 92
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 92
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study. 91
Nox2 activation in covid-19 91
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients 91
Lack of community-associated MRSA in Rome 89
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis 89
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 88
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 88
Pacemaker Lead Endocarditis Due to Multidrug-Resistant Corynebacterium striatum Detected with Sonication of the Device 88
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 87
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 86
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 86
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 86
Molecular diagnosis of SARS-CoV-2 in seminal fluid 86
Rubella Susceptibility Profile in Pregnant Women with HIV 85
Diplopia as isolated presentation of varicella zoster central nervous system reactivation 85
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 85
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 85
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV 85
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients 85
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection. A scoping review 85
Glucose Plasma Levels and Pregnancy Outcomes in Women with HIV 84
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA 84
Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care teaching hospital in Italy: A retrospective analysis 84
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 84
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 84
Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain 83
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 83
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice. Evidence of a relevant risk of death and evolution from silent to chronic infection 83
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen 83
Abdominal aortic mycotic aneurysm, psoas abscess, and aorto-bisiliac graft infection due to Salmonella typhimurium. 82
Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression 82
Epidemiology of Chronic Pain in the Latium Region, Italy. a Cross-sectional Study on the Clinical Characteristics of Patients Attending Pain Clinics 82
Dirofilaria repens infection mimicking lung melanoma metastasis 82
Atypical presentation of crusted (Norwegian) scabies 82
Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients 82
Diagnostic and therapeutic approach in a rare case of primary bilateral adrenal tuberculosis 82
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 82
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 82
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. 81
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 81
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 81
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers 81
Cellule dendritiche del sangue periferico e delle urine nel cancro della vescica. 80
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 80
Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women 80
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy. A prospective case-control study 80
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone 79
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection 79
Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases 79
Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis 78
Case report: human papilloma virus type 120-related papillomatosis mimicking laryngeal carcinoma 78
Bartonella henselae infection presenting with ocular and hepatosplenic manifestations in an immunocompetent child 78
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 78
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 78
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence 78
Totale 9.628
Categoria #
all - tutte 116.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.290 0 0 0 0 0 1.099 954 708 611 470 221 227
2020/20213.003 279 299 82 179 145 334 75 234 371 527 277 201
2021/20226.472 125 343 541 343 702 243 243 625 656 410 1.120 1.121
2022/20236.768 1.250 1.390 390 700 634 599 132 612 556 92 254 159
2023/20244.215 247 446 213 307 407 638 160 373 69 528 378 449
2024/20252.923 358 538 635 696 688 8 0 0 0 0 0 0
Totale 34.300